Modular minimally invasive extracorporeal circulation systems; can they become the standard practice for performing cardiac surgery?

Minimally invasive extracorporeal circulation (MiECC) has been developed in an attempt to integrate all advances in cardiopulmonary bypass technology in one closed circuit that shows improved biocompatibility and minimizes the systemic detrimental effects of CPB. Despite well-evidenced clinical advantages, penetration of MiECC technology into clinical practice is hampered by concerns raised by perfusionists and surgeons regarding air handling together with blood and volume management during CPB. We designed a modular MiECC circuit, bearing an accessory circuit for immediate transition to an open system that can be used in every adult cardiac surgical procedure, offering enhanced safety features. We challenged this modular circuit in a series of 50 consecutive patients. Our results showed that the modular AHEPA circuit design offers 100% technical success rate in a cohort of random, high-risk patients who underwent complex procedures, including reoperation and valve and aortic surgery, together with emergency cases. This pilot study applies to the real world and prompts for further evaluation of modular MiECC systems through multicentre trials.

[1]  N. Maniadakis,et al.  Coronary artery bypass grafting with minimal versus conventional extracorporeal circulation; an economic analysis. , 2013, International journal of cardiology.

[2]  C. Asteriou,et al.  Enhanced recovery after elective coronary revascularization surgery with minimal versus conventional extracorporeal circulation: a prospective randomized study. , 2013, Journal of cardiothoracic and vascular anesthesia.

[3]  A. Haidich,et al.  Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials. , 2013, International journal of cardiology.

[4]  C. Foroulis,et al.  Minimal extracorporeal circulation reduces the incidence of postoperative major adverse events after elective coronary artery bypass grafting in high-risk patients. A single-institutional prospective randomized study , 2013, Perfusion.

[5]  P. Jungebluth,et al.  Minimized perfusion circuits: an alternative in the surgical treatment of Jehovah’s Witnesses , 2013, Perfusion.

[6]  A. Simons,et al.  Can minimized cardiopulmonary bypass systems be safer? , 2012, Perfusion.

[7]  R. Hetzer,et al.  In Intensive Care Cardiovascular Anesthesia Expert Opinion , 2022 .

[8]  T. Hájek,et al.  Are minimized perfusion circuits the better heart lung machines? Final results of a prospective randomized multicentre study , 2011, Perfusion.

[9]  H. Hausmann,et al.  Evaluation of hemodynamic and regional tissue perfusion effects of minimized extracorporeal circulation (MECC). , 2010, The journal of extra-corporeal technology.

[10]  G. Rakhorst,et al.  Attenuated renal and intestinal injury after use of a mini-cardiopulmonary bypass system. , 2007, The Annals of thoracic surgery.

[11]  A. Liebold,et al.  Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. , 2004, Artificial organs.